Results 21 to 30 of about 908,735 (292)
The Impact of beta blockade on the cardio-respiratory system and symptoms during exercise
Current Research in Physiology, 2021 Background: Beta blockers prolong life in patients with cardiovascular diseases. Negative chronotropic and inotropic effects carry the potential to adversely effect peripheral skeletal and airway smooth muscle contributing to further fatigue, dyspnea and
Eldar Priel +6 more
doaj +1 more source
Heart rate and use of beta-blockers in stable outpatients with coronary artery disease [PDF]
, 2012 <p><b>Background:</b> Heart rate (HR) is an emerging risk factor in coronary artery disease (CAD). However, there is little contemporary data regarding HR and the use of HR-lowering medications, particularly beta-blockers, among ...
Abergel, Helene +66 more
core +1 more source
Effect of prostaglandins and beta blockers on progression of hypertensive and normotensive glaucomas
, 2021 Aim. The aim of the study was to evaluate the progression of changes in the visual fields in patients with hypertensive glaucoma (HTG) and normotensive glaucoma (NTG) following administration of prostaglandins and beta blockers, as well as also in NTG ...
Klara Maresova +3 more
core +1 more source
A Clinical-Epidemiological Study on Beta-Blocker Poisonings Based on the Type of Drug Overdose
Journal of Toxicology, 2023 Background. Beta‐blockers carry a high risk of potentially causing fatal poisoning if overdosed. We aimed to assess the clinical and epidemiological characteristics of patients with beta-blocker poisoning. Methods.
Nastaran Eizadi-Mood +4 more
doaj +1 more source
Beta adrenergic blockers poisoning [PDF]
ABC: časopis urgentne medicine, 2016 AIM: To demonstrate the basic characteristics in terms of clinical features and a basic method of treatment in β-adrenergic blockers poisoning. MATERIALS AND METHODS: Review of the available literature, the protocols of departments that participated in ...
Tadić Milorad, Stanimirović Marijana
doaj
National Journal of Physiology, Pharmacy and Pharmacology, 2020 Background: Beta-blockers with additional beneficial activity such as beta-2 agonist and alpha-1 blocking activity are developed and available as the third-generation beta-blockers for effective management of hypertension with comorbid conditions ...
Haripriya Sadam, Subash K R
doaj +1 more source
The place of metoprolol tartrate in the treatment of cardiovascular diseases
Медицинский совет, 2016 Since the beginning of the 1960s, beta-blockers have been number one medications in the treatment of cardiovascular diseases. A number of randomized controlled trials (RCTs) demonstrated positive effect of beta-blockers on morbidity and mortality [1]. It
N. V. Romanova, I. V. Zhirov
doaj +1 more source
Journal of Hepatology, 2014 might have stumbled across other rather informative (and much We read with interest the recent review on beta-blockers in cirrhosis by Ge and Runyon [1]. This topic is of great importance, as non-selective beta blockers are a pharmacological mainstay in the management of patients with cirrhosis; the amount of evidence has been increasing substantially ...
Thalheimer, Ulrich +2 more
openaire +2 more sources
Antihypertensive Drug Use and the Risk of Depression: A Systematic Review and Network Meta-analysis
Frontiers in Pharmacology, 2021 Background: Although numerous cohort studies have reported an association between antihypertensives use and depression, the exact effect of antihypertensives on depression remains unclear.Objective: To clarify the association between antihypertensives ...
Ying Li +5 more
doaj +1 more source
Pharmaceuticals in the aquatic environment: β-blockers as a case study [PDF]
, 2008 This thesis was submitted for the degree of Doctor of Philosophy and awarded by Brunel University, 20/09/2008.The presence of many human pharmaceuticals in the aquatic environment is now a worldwide concern and yet little is known of the chronic effects ...
Giltrow, Emma
core +7 more sources